Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus

Journal of Medical Virology

Volumn 67, Issue 3, 2002, Pages 384-393

  Elvin, Stephen J ^a   Bennett, Alice M ^a   Phillpotts, Robert J ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Mucosal immunity; Protection; VEEV

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TC 83; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; SPLEEN CELL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ISOLATION; VIRUS TRANSMISSION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CELL LINE; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNIZATION, PASSIVE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NASAL MUCOSA; SPLEEN; VACCINES, ATTENUATED; VIRAL VACCINES;

EQUIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0036274001     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10086     Document Type: Article

References (42)

1. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man
2. Improved protection against Venezuelan encephalitis by genetic engineering of a recombinant vaccinia virus
3. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine
4. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig-heart cells
5. TC-83 Venezuelan equine encephalitis exposure during pregnancy
6. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse
7. Mucosal immunity induced by parenteral immunisation with a live attenuated Venezuelan equine encephalitis virus vaccine candidate
8. Effecto teratogenico del virus de la encefalitis equina Venezolana, una revision del problema
9. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine
10. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins
11. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus
12. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in Balb/c mice but not C3H/HeN mice
13. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate
14. Optimal induction of upper respiratory tract immunity to reovirus 1/L by combined upper and lower respiratory tract inoculation
15. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters
16. Protective efficacies of live attenuated and formaldehyde inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters
17. Alphaviruses
18. Different roles for cytotoxic T cells in the control the control of infections with cytopathic versus noncytopathic viruses
19. A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μchain gene
20. Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague
21. Pegylated alpha interferon is an effective treatment for virulent Venezuelan equine encephalitis virus and has profound effects on the host immune response to infection
22. Specificity of the murine T helper cell immune response to various alphaviruses
23. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalitis virus infection with glycoprotein specific monoclonal antibodies
24. Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus
25. Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus
26. The alphaviruses
27. CD4+ T cell activation and tolerance in B cell knockout mice
28. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunisation with the attenuated vaccine strain TC-83
29. TC-83 vaccine protects against airborne or sub-cutaneous challenge with heterologous mouse virulent strains of Venezuelan equine encephalitis virus
30. A simple device for the exposure of animals to infectious microorganisms by the airborne route
31. Long term duration of detectable neutralising antibodies after administration of live attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
32. Virus induced pancreatid disease by Venezuelan equine encephalitis virus. Alterations in glucose tolerance and insulin release
33. Passive transfer of local immunity to influenza virus infection by IgA antibody
34. Epidemic Venezuelan equine encephalitis in La Guarija, Columbia, 1995
35. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice
36. Spread of Venezuelan equine encephalitis virus in mice olfactory tract
37. Nonneutralising monoclonal antibodies can prevent lethal alphavirus encephalitis
38. Early expression of IFN-α/β and iNOS in the brains of Venezuelan encephalitis virus-infected mice
39. Nonvascular delivery of St. Louis encephalitis and Venezuelan equine encephalitis viruses by infected mosquitoes (Diptera: Culicidae) feeding on a vertebrate host
40. Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis
41. Necrosis cerebra massiva del feto en casos de encefalitis equina Venezolana
42. Humane endpoints are an objective measure of morbidity in Venezuelan equine encephalomyelitis virus infection of mice